Antidepressants for the treatment of insomnia: A suitable approach?

Drugs

Volumn 68, Issue 17, 2008, Pages 2411-2417

  Wiegand, Michael H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antidepressants, therapeutic use; Insomnia, treatment

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DOXEPIN; ESZOPICLONE; LORMETAZEPAM; MELATONIN; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRIMIPRAMINE; ZOLPIDEM;

AGITATION; BLOOD PRESSURE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; HEADACHE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSOMNIA; LEUKOPENIA; MUSCLE HYPOTONIA; NERVOUSNESS; OFF LABEL DRUG USE; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; VOMITING;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEASIBILITY STUDIES; HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 56549087837     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/0003495-200868170-00001     Document Type: Review

References (35)

1. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Int Med 2006; 22: 1335-50
2. Nowell PD, Mazumdar S, Buysse DJ, et al. Benzodiazepines and zolpidem for chronic insomnia. J Amer Med Assoc 1997; 278: 2170-7
3. Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162: 225-33
4. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159: 5-11
5. Glass J, Lanctot K, Hermann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 2005; 331: 1169
6. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26: 793-9
7. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 2007; 30: 959-68
8. Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12,5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blined, placebo-controlled, parallel-group, multicenter study. Sleep 2008; 31: 79-90
9. Mendelson WB, Roth T, Cassella J, et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit Meeting Symposium. Sleep Med Rev 2004; 8: 7-17
10. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999; 22: 371-5
11. Anonymous. What's wrong with prescribing hypnotics? Drugs Ther Bull2004; 42 (12): 89-93
12. Walsh JK. Pharmacologic management of insomnia. J Clin Psychiatry 2004; 65 Suppl. 16: 41-5
13. Reite M, Ruddy J, Nagel K. Concise guide to evaluation and management of sleep disorders. 3rd ed. Washington, DC: American Psychiatric Publishing, Inc., 2002
14. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005; 65 (7): 927-47
15. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol Clin Exp 2005; 20: 533-59
16. Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001 Jun; 62: 453-63
17. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSM III-R primary insomnia. Hum Psychopharmacol Clin Exp 1998; 13: 191-8
18. Riemann D, Voderholzer U, Cohrs S, et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 2002; 35: 165-74
19. Buysse DJ, Reynolds III CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
20. Görtelmeyer R. On the development of a standardized sleep inventory for assessment of sleep. In: Kubicki S, Hermann VW, editors. Methods of sleep research. Stuttgart: Fischer, 1985: 93-8
21. Hajak G, Rodenbeck A, Adler L, et al. Nocturnal melatonion secretion and sleep after doxepin administration in chronic primary insomnia. Pharmacopsychiatry 1996; 29 (5): 187-92
22. Wiegand MH, Galanakis P, Schreiner R. Nefazodone in primary insomnia: an open pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1071-8
23. Nowell PD, Reynolds CF, Buysse DJ, et al. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 1999; 60: 89-95
24. Hohagen F, Fritsch Montero R, Weiss E, et al. Treatment of primary insomnia with trimipramine: an alternative to benzo-diazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 1994; 242: 329-36
25. Krystal AD. The changing perspective on chronic insomnia management. J Clin Psychiatry 2004; 65 Suppl. 8: 20-5
26. Ermann MK. Therapeutic options in the treatment of insomnia. J Clin Psychiatry 2005; 66 Suppl. 9: 18-23
27. Hajak G. Therapeutics in insomnia: new paradigms in pharmacological treatment of insomnia. Sleep Med 2005; 7 Suppl. 1: S20-36
28. Wiegand MH, Landry F, Brückner T, et al. Quetiapine in primary insomnia: a pilot study. Psychopharmacology (Berl) 2008; 196: 337-8
29. Hajak G, Rodenbeck A, Bandelow B, et al. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects. Eur Neuropsychopharmacol 1996; 6: 149-53
30. Ghosh A, Hellewell JS. A review of the efficacy of agomelatine in the treatment of major depression. Expert Opin Investig Drugs 2007; 16: 1999-2004
31. Adis R&D Profile. Agomelatine: AGO 178, AGO178, S 20098. Drugs R D 2008; 9: 177-83
32. Benkert O, Hippius H. Kompendium der psychiatrischen Pharmakotherapie. Heidelberg: Springer, 2007
33. Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999; 60: 668-76
34. Becker PM. Treatment of sleep dysfunction and psychiatric disorders. Curr Treat Options Neurol 2006; 8: 367-75
35. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008; 65: 551-62